Thoth Biosimulations Named to Edmonton 50 by ScaleUp Canada

We’re thrilled to announce that Thoth Biosimulations has been named to the Edmonton 50, a prestigious list recognizing the region’s most promising and scalable companies. The list is curated by ScaleUp Canada, an initiative that spotlights high-growth ventures poised to make a national and global impact.

This recognition highlights Thoth’s progress in advancing AI-driven drug discovery through our flagship platform, AI-MedCraft, and our commitment to building a globally competitive biotech company rooted in Alberta.

Being selected as one of the Edmonton 50 reinforces the value of our innovation, the dedication of our team, and the strength of our vision to reshape drug discovery with generative AI.

We extend our thanks to ScaleUp CanadaAlberta InnovatesEdmonton Unlimited, and all of our supporters who continue to champion our journey. The future of drug discovery is here — and it’s being built in Edmonton.

Edmonton 50 by ScaleUp Canada

Next
Next

Thoth CEO Delivers Joint Keynote at UBC Science Research Mixer